Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Akoya Biosciences, Inc. AKYA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.40
+86%

Akoya Biosciences, Inc. (AKYA) has 12 identified peers for comparison in the Healthcare sector. Peers include ANGO, ATR, ATRC, ATRI, COO, HAE and others.

AKYA has a market capitalization of $64.44M, compared to an average peer market cap of $2.87B. AKYA is notably smaller than its average peer.

People Also View

COO
COO
The Cooper Companies, Inc.
$71.61
-0.13%
 ATR
ATR
AptarGroup, Inc.
$131.01
-0.83%
 ICUI
ICUI
ICU Medical, Inc.
$127.85
-1.14%
 HAE
HAE
Haemonetics Corporation
$60.48
+2.04%
 LMAT
LMAT
LeMaitre Vascular, Inc.
$117.39
+1.93%
 ATRC
ATRC
AtriCure, Inc.
$29.40
+2.58%
 ATRI
ATRI
Atrion Corporation
$459.92
+0.06%
 ANGO
ANGO
AngioDynamics, Inc.
$10.47
+2.25%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message